Home

Abdeckung niesen Anzai puma biotechnology stock news Grüßen Glühen Scheitel

Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?

PBYI Stock Forecast, Price & News (Puma Biotechnology)
PBYI Stock Forecast, Price & News (Puma Biotechnology)

With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is  a favorite amongst the big guns | Nasdaq
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq

Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA  Approval for NERLYNX - Warrior Trading News
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News

Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Announces $10 Million Private Placement | Business Wire

Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA  Approval for NERLYNX - Warrior Trading News
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News

Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) |  Seeking Alpha
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha

PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's

Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool

Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital |  Business Wire
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire

Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology - Crunchbase Company Profile & Funding

Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News - Stock Analysis

Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A  Buy-In Opportunity - Market Exclusive
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive

Puma Biotechnology Inc
Puma Biotechnology Inc

Why Puma Biotechnology, Applied Optoelectronics, and Ferroglobe Jumped  Today | The Motley Fool
Why Puma Biotechnology, Applied Optoelectronics, and Ferroglobe Jumped Today | The Motley Fool

News Release
News Release

Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?

Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Announces $10 Million Private Placement | Business Wire

Puma Biotechnology falls more than 20%
Puma Biotechnology falls more than 20%

PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener

Articles with Puma Biotechnology
Articles with Puma Biotechnology

Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News  & Stock Market Analysis - IBD
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD

Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool

PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc  (NASDAQ) Stock
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock

Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.
Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.

Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha

Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com